Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “neurofibromatosis1 (NF1)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Active Not RecruitingNCT03975829
What this trial is testing

Pediatric Long-Term Follow-up and Rollover Study

Who this might be right for
Diffuse AstrocytomaAnaplastic AstrocytomaAstrocytoma+20 more
Novartis Pharmaceuticals 163
Post-approval studies (Phase 4)Study completedNCT00169611
What this trial is testing

NF1-Attention: Study of Children With Neurofibromatosis Type 1 Treated by Methylphenidate

Who this might be right for
Neurofibromatosis Type 1
Hospices Civils de Lyon 80
Not applicableStudy completedNCT02479360
What this trial is testing

Reliability of Functional Outcome Measures in Neurofibromatosis 1

Who this might be right for
Neurofibromatosis 1, NF1
Guy's and St Thomas' NHS Foundation Trust 49
Not applicableStudy completedNCT00303368
What this trial is testing

Neurofibromatosis Type 1 (NF1) and Tibial Dysplasia

Who this might be right for
Neurofibromatosis Type 1Tibial Dysplasia
Shriners Hospitals for Children 395
Not applicableStudy completedNCT01800032
What this trial is testing

PET/MRI in CNS and Extra-CNS Tumors of Patients With Neurofibromatosis-1 (NF1)

Who this might be right for
Neurofibromatosis-1Optic GliomaPlexiform Neurofibroma
UNC Lineberger Comprehensive Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT03231306
What this trial is testing

Phase II Study of Binimetinib in Children and Adults With NF1 Plexiform Neurofibromas

Who this might be right for
Neurofibromatosis Type 1Plexiform Neurofibroma
University of Alabama at Birmingham 45
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06763315
What this trial is testing

Low-dose Selumetinib for the Treatment of Plexiform Neurofibromas in Chinese Children

Who this might be right for
Plexiform Neurofibromas (PN)
West China Hospital 50
Testing effectiveness (Phase 2)Looking for participantsNCT06735820
What this trial is testing

Early Phase Study Evaluating MEK and MDM2 Inhibition in Patients With NF1 and MPNST

Who this might be right for
Malignant Peripheral Nerve Sheath Tumor (MPNST)Neurofibromatosis 1 (NF1)Atypical Neurofibroma
AeRang Kim 45
Not applicableLooking for participantsNCT06523582
What this trial is testing

Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients

Who this might be right for
Neuroendocrine NeoplasmNeuroendocrine Neoplasm of Gastrointestinal TractNeuroendocrine Neoplasm of Lung+23 more
Universidad Nacional Autonoma de Mexico 750
Not applicableStudy completedNCT04941027
What this trial is testing

Evaluating Genetic Modifiers of Cutaneous Neurofibromas in Adults With Neurofibromatosis Type 1

Who this might be right for
Neurofibromatosis 1
Stanford University 1,046
Testing effectiveness (Phase 2)Active Not RecruitingNCT01362803
What this trial is testing

AZD6244 Hydrogen Sulfate for Children With Nervous System Tumors

Who this might be right for
Neurofibromatosis 1Neurofibromatosis Type 1NF1+1 more
National Cancer Institute (NCI) 99
Testing effectiveness (Phase 2)Study completedNCT00853580
What this trial is testing

Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1

Who this might be right for
Neurofibromatosis Type 1
University of Alabama at Birmingham 146
Testing effectiveness (Phase 2)Study completedNCT05005845
What this trial is testing

NFX-179 Topical Gel Treatment for Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF)

Who this might be right for
Cutaneous NeurofibromaNeurofibromatosis 1
NFlection Therapeutics, Inc. 199
Not applicableStudy completedNCT03672838
What this trial is testing

A Single Center Pilot Study to Assess the Intra-observer Reliability of Measuring Muscle Strength Using a Hand Held Dynamometer in Children and Adults With Neurofibromatosis Type 1 (NF1) and Type 2 (NF2)

Who this might be right for
Neurofibromatosis 1 and 2 (NF1 and NF2)
NYU Langone Health 33
Not applicableStudy completedNCT05149469
What this trial is testing

Molecular Aspects of Preimplantation Genetic Diagnosis for NF1

Who this might be right for
Neurofibromatosis Type 1
University Hospital, Strasbourg, France 60
Testing effectiveness (Phase 2)Ended earlyNCT02728388
What this trial is testing

Photodynamic Therapy for Benign Dermal Neurofibromas- Phase II

Who this might be right for
NEUROFIBROMATOSIS 1
Donald Basel 30
Not applicableStudy completedNCT00844129
What this trial is testing

Spinal Abnormalities in Neurofibromatosis Type 1 (NF1)

Who this might be right for
Neurofibromatosis Type 1
University of Utah 112
Early research (Phase 1)Looking for participantsNCT07102394
What this trial is testing

Feasibility and Tolerability of IMLYGIC for the Treatment of Cutaneous Neurofibromas in Adults With NF1

Who this might be right for
NF1NeurofibromatosisCutaneous Neurofibroma+3 more
Johns Hopkins University 10
Not applicableStudy completedNCT02298270
What this trial is testing

Resiliency Training for Patients With Neurofibromatosis Via Videoconferencing With Skype

Who this might be right for
NeurofibromatosisNeurofibromatosis INeurofibromatosis 2+1 more
Massachusetts General Hospital 65
Testing effectiveness (Phase 2)Study completedNCT03433183
What this trial is testing

SARC031: MEK Inhibitor Selumetinib (AZD6244) in Combination With the mTOR Inhibitor Sirolimus for Patients With Malignant Peripheral Nerve Sheath Tumors

Who this might be right for
Malignant Peripheral Nerve Sheath TumorsNeurofibromatosis 1
Sarcoma Alliance for Research through Collaboration 21
Next Page